litlas
ログインアカウント作成

Niklas Mattsson

1999–2025 年に発表

225
論文数
41,108
被引用数
105
h 指数
214
i10 指数

被引用数

Niklas Mattsson の年別被引用数1967 年: 被引用 1 件1988 年: 被引用 6 件2000 年: 被引用 2 件2001 年: 被引用 12 件2002 年: 被引用 8 件2003 年: 被引用 3 件2004 年: 被引用 2 件2005 年: 被引用 1 件2006 年: 被引用 3 件2007 年: 被引用 2 件2008 年: 被引用 7 件2009 年: 被引用 26 件2010 年: 被引用 59 件2011 年: 被引用 54 件2012 年: 被引用 88 件2013 年: 被引用 85 件2014 年: 被引用 128 件2015 年: 被引用 156 件2016 年: 被引用 242 件2017 年: 被引用 326 件2018 年: 被引用 473 件2019 年: 被引用 1,208 件2020 年: 被引用 1,950 件2021 年: 被引用 2,517 件2022 年: 被引用 2,647 件2023 年: 被引用 2,323 件2024 年: 被引用 3,970 件2025 年: 被引用 2,620 件2026 年: 被引用 114 件1968〜1987 年は被引用が無いため表示していません1989〜1999 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,068 件、この内訳の 21.1%イギリス: 引用元論文 1,976 件、この内訳の 10.3%スウェーデン: 引用元論文 1,639 件、この内訳の 8.5%中国: 引用元論文 1,518 件、この内訳の 7.9%ドイツ: 引用元論文 996 件、この内訳の 5.2%オランダ: 引用元論文 826 件、この内訳の 4.3%イタリア: 引用元論文 779 件、この内訳の 4%スペイン: 引用元論文 732 件、この内訳の 3.8%カナダ: 引用元論文 704 件、この内訳の 3.7%フランス: 引用元論文 643 件、この内訳の 3.3%オーストラリア: 引用元論文 524 件、この内訳の 2.7%スイス: 引用元論文 489 件、この内訳の 2.5%
0%21.1%その他 22.7%

機関

分野

  • Medicine71.3%
  • Neuroscience12.6%
  • Biochemistry, Genetics and Molecular Biology9.8%
  • Computer Science1%
  • Immunology and Microbiology0.9%
  • Psychology0.7%
  • その他3.7%

トピック

  • Alzheimer's disease research and treatments17.7%
  • Dementia and Cognitive Impairment Research15.2%
  • Functional Brain Connectivity Studies3.2%
  • Neuroinflammation and Neurodegeneration Mechanisms2.8%
  • Parkinson's Disease Mechanisms and Treatments2.1%
  • Neurological Disease Mechanisms and Treatments2.1%
  • その他56.9%

共著者

全論文

検索で開く
  1. Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders

    著者: Sebastian Palmqvist, Shorena Janelidze, Yakeel T. Quiroz, Henrik Zetterberg, Francisco Lopera, Erik Stomrud, Yi Su, Yinghua Chen, Geidy E. Serrano, Antoine Leuzy, Niklas Mattsson, Olof Strandberg, Ruben Smith, Andrés Villegas, Diego Sepúlveda‐Falla, Xiyun Chai, Nicholas K. Proctor, Thomas G. Beach, Kaj Blennow, Jeffrey L. Dage, Eric M. Reiman, Oskar Hansson - JAMA 2020 被引用: 1,546

  2. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

    著者: Thomas K. Karikari, Tharick A. Pascoal, Nicholas J. Ashton, Shorena Janelidze, Andréa Lessa Benedet, Juan Lantero‐Rodriguez, Mira Chamoun, Mélissa Savard, Min Su Kang, Joseph Therriault, Michael Schöll, Gassan Massarweh, Jean-Paul Soucy, Kina Höglund, Gunnar Brinkmalm, Niklas Mattsson, Sebastian Palmqvist, Serge Gauthier, Erik Stomrud, Henrik Zetterberg, Oskar Hansson, Pedro Rosa‐Neto, Kaj Blennow - The Lancet Neurology 2020 被引用: 1,360

  3. Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia

    著者: Shorena Janelidze, Niklas Mattsson, Sebastian Palmqvist, Ruben Smith, Thomas G. Beach, Geidy E. Serrano, Xiyun Chai, Nicholas K. Proctor, Udo Eichenlaub, Henrik Zetterberg, Kaj Blennow, Eric M. Reiman, Erik Stomrud, Jeffrey L. Dage, Oskar Hansson - Nature Medicine 2020 被引用: 1,271

  4. Highly accurate blood test for Alzheimer’s disease is similar or superior to clinical cerebrospinal fluid tests

    著者: Nicolas R Barthélemy, Gemma Salvadó, Suzanne E. Schindler, Yingxin He, Shorena Janelidze, Lyduine E. Collij, Benjamin Saef, Rachel L. Henson, Charles D. Chen, Brian A. Gordon, Yan Li, Renaud La Joie, Tammie L.S. Benzinger, John C. Morris, Niklas Mattsson, Sebastian Palmqvist, Rik Ossenkoppele, Gil D. Rabinovici, Erik Stomrud, Randall J. Bateman, Oskar Hansson - Nature Medicine 2024 被引用: 408

  5. Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring

    著者: Nicholas J. Ashton, Shorena Janelidze, Niklas Mattsson, Alexa Pichet Binette, Olof Strandberg, Wagner S. Brum, Thomas K. Karikari, Fernando González‐Ortiz, Guglielmo Di Molfetta, Francisco J. Meda, Erin M. Jonaitis, Rebecca L. Koscik, Karly Alex Cody, Tobey J. Betthauser, Yan Li, Eugeen Vanmechelen, Sebastian Palmqvist, Erik Stomrud, Randall J. Bateman, Henrik Zetterberg, Sterling C. Johnson, Kaj Blennow, Oskar Hansson - Nature Medicine 2022 被引用: 431

  6. Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia

    著者: Willemijn J. Jansen, Rik Ossenkoppele, Dirk L. Knol, Betty M. Tijms, Philip Scheltens, Frans R.J. Verhey, Pieter Jelle Visser, Pauline Aalten, Dag Aarsland, Daniel Alcolea, M Alexander, Ina S. Almdahl, Steven E. Arnold, Inês Baldeiras, Henryk Barthel, Bart N.M. van Berckel, Kristen Bibeau, Kaj Blennow, David J. Brooks, Mark A. van Buchem, Vincent Camus, Enrica Cavedo, Kewei Chen, Gaël Chételat, Ann D. Cohen, Alexander Drzezga, Sebastiaan Engelborghs, Anne M. Fagan, Tormod Fladby, Adam Fleisher, Wiesje M. van der Flier, Lisa Ford, Stefan Förster, Juan Fortea, Nadia Foskett, Kristian Steen Frederiksen, Yvonne Freund‐Levi, Giovanni B. Frisoni, Lutz Froelich, Tomasz Gabryelewicz, Kiran Dip Gill, Olymbia Gkatzima, Estrella Gómez‐Tortosa, Mark Forrest Gordon, Timo Grimmer, Harald Hampel, Lucrezia Hausner, Sabine Hellwig, Sanna‐Kaisa Herukka, Helmut Hildebrandt, Lianna Ishihara, Adrian Ivanoiu, William J. Jagust, Peter Johannsen, Ramesh Kandimalla, Elisabeth Kapaki, Aleksandra Klimkowicz‐Mrowiec, William E. Klunk, Sebastian Köhler, Norman Koglin, Johannes Kornhuber, Milica G. Kramberger, Koen Van Laere, Susan Landau, Dong Young Lee, Mony J. de Leon, Viviana Lisetti, Alberto Lleó, Karine Madsen, Wolfgang Maier, Jan Marcusson, Niklas Mattsson, Alexandre de Mendonça, Olga Meulenbroek, Philipp T. Meyer, Mark A. Mintun, Vincent Mok, José Luís Molinuevo, Hanne M. Møllergård, John C. Morris, Barbara Mroczko, Stefan Van der Mussele, Duk L. Na, Andrew B. Newberg, Agneta Nordberg, Arto Nordlund, Gerald Novak, George P. Paraskevas, Lucilla Parnetti, Gayan Perera, Oliver Peters, Julius Popp, Sudesh Prabhakar, Gil D. Rabinovici, Inez H.G.B. Ramakers, Lorena Rami, Catarina R. Oliveira, Juha O. Rinne, Karen M. Rodrigue, Eloy Rodríguez‐Rodríguez ほか 29 名 - JAMA 2015 被引用: 1,635

  7. Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study

    著者: Elisabeth H. Thijssen, Renaud La Joie, Amelia Strom, Corrina Fonseca, Leonardo Iaccarino, Amy Wolf, Salvatore Spina, Isabel Elaine Allen, Yann Cobigo, Hilary W. Heuer, Lawren VandeVrede, Nicholas K. Proctor, Argentina Lario Lago, Suzanne L. Baker, Rajeev Sivasankaran, Agnieszka Kieloch, Arvind G. Kinhikar, Lili Yu, Marie‐Anne Valentin, Andreas Jeromin, Henrik Zetterberg, Oskar Hansson, Niklas Mattsson, Danielle Graham, Kaj Blennow, Joel H. Kramer, Lea T. Grinberg, William W. Seeley, Howard J. Rosen, Bradley F. Boeve, Bruce L. Miller, Charlotte E. Teunissen, Gil D. Rabinovici, Julio C. Rojas, Jeffrey L. Dage, Adam L. Boxer - The Lancet Neurology 2021 被引用: 592

  8. Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease

    著者: Joana B Pereira, Shorena Janelidze, Ruben Smith, Niklas Mattsson, Sebastian Palmqvist, Charlotte E. Teunissen, Henrik Zetterberg, Erik Stomrud, Nicholas J. Ashton, Kaj Blennow, Oskar Hansson - Brain 2021 被引用: 587

  9. Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets

    著者: Jing Hua Zhao, David Stacey, Niclas Eriksson, Erin Macdonald-Dunlop, Åsa K. Hedman, Anette Kalnapenkis, Stefan Enroth, Domenico Cozzetto, Jonathan Digby‐Bell, Jonathan Marten, Lasse Folkersen, Christian Herder, Lina Jönsson, Sarah E. Bergen, Christian Gieger, Elise J. Needham, Praveen Surendran, Andres Metspalu, Lili Milani, Reedik Mägi, Mari Nelis, Georgi Hudjašov, Dirk S. Paul, Ozren Polašek, Barbara Thorand, Harald Grallert, Michael Roden, Urmo Võsa, Tõnu Esko, Caroline Hayward, Åsa Johansson, Ulf Gyllensten, Nick Powell, Oskar Hansson, Niklas Mattsson, Peter K. Joshi, John Danesh, Leonid Padyukov, Lars Klareskog, Mikael Landén, James F. Wilson, Agneta Siegbahn, Lars Wallentin, Anders Mälarstig, Adam S. Butterworth, James E. Peters - Nature Immunology 2023 被引用: 729

  10. Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease

    著者: Niklas Mattsson, Ulf Andréasson, Henrik Zetterberg, Kaj Blennow, for the Alzheimer’s Disease Neuroimaging Initiative - JAMA Neurology 2017 被引用: 1,081

  11. Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measures

    著者: Sebastian Palmqvist, Pontus Tideman, Nicholas Cullen, Henrik Zetterberg, Kaj Blennow, the Alzheimer’s Disease Neuroimaging Initiative, Jeffrey L. Dage, Erik Stomrud, Shorena Janelidze, Niklas Mattsson, Oskar Hansson - Nature Medicine 2021 被引用: 534

  12. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease

    著者: Niklas Mattsson, Nicholas Cullen, Ulf Andréasson, Henrik Zetterberg, Kaj Blennow - JAMA Neurology 2019 被引用: 740

  13. Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity

    著者: Sebastian Palmqvist, Michael Schöll, Olof Strandberg, Niklas Mattsson, Erik Stomrud, Henrik Zetterberg, Kaj Blennow, Susan Landau, William J. Jagust, Oskar Hansson - Nature Communications 2017 被引用: 947

  14. Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers

    著者: Niklas Mattsson, Gemma Salvadó, Nicholas J. Ashton, Pontus Tideman, Erik Stomrud, Henrik Zetterberg, Rik Ossenkoppele, Tobey J. Betthauser, Karly Alex Cody, Erin M. Jonaitis, Rebecca Langhough, Sebastian Palmqvist, Kaj Blennow, Shorena Janelidze, Sterling C. Johnson, Oskar Hansson - JAMA Neurology 2023 被引用: 295

  15. Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology

    著者: Claire Bridel, Wessel N. van Wieringen, Henrik Zetterberg, Betty M. Tijms, Charlotte E. Teunissen, and the NFL Group, José C. Álvarez‐Cermeño, Ulf Andréasson, Markus Axelsson, David Bäckström, Aleš Bartoš, Maria Bjerke, Kaj Blennow, Adam L. Boxer, Lou Brundin, Joachim Burman, Tove Christensen, L Fialová, Lars Forsgren, Jette Lautrup Frederiksen, Magnus Gisslén, Elizabeth Gray, Martin Gunnarsson, Sara Hall, Oskar Hansson, Megan K. Herbert, Joel Jakobsson, Jan Jessen-Krut, Shorena Janelidze, Gudmundur Johannsson, Michael Jonsson, Ludwig Kappos, Mohsen Khademi, Michael Khalil, Jens Kühle, Mikael Landén, Ville Leinonen, Giancarlo Logroscino, Ching‐Hua Lu, Jan Lycke, Nadia Magdalinou, Andrea Malaspina, Niklas Mattsson, Lieke Meeter, Sanjay R. Mehta, Signe Modvig, Tomas Olsson, Ross W. Paterson, Josué Pérez‐Santiago, Fredrik Piehl, Yolande A.L. Pijnenburg, Okko T. Pyykkö, Óskar Ragnarsson, Julio C. Rojas, Jeppe Romme Christensen, Linda Sandberg, Carole Scherling, Jonathan M. Schott, Finn Sellebjerg, Isabella Laura Simone, Tobias Skillbäck, Morten Stilund, Peter Sundström, Anders Svenningsson, Rosanna Tortelli, Carla Tortorella, Alessandro Trentini, Maria Troiano, Martin R. Turner, John C. van Swieten, Mattias Vågberg, Marcel M. Verbeek, Luisa María Villar, Pieter Jelle Visser, Anders Wallin, Andreas Weiss, Carsten Wikkelsø, Edward J. Wild - JAMA Neurology 2019 被引用: 760

  16. CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s disease

    著者: Kanta Horie, Gemma Salvadó, Nicolas R. Barthélemy, Shorena Janelidze, Yan Li, Yingxin He, Benjamin Saef, Charles D. Chen, Hong Jiang, Olof Strandberg, Alexa Pichet Binette, Sebastian Palmqvist, Chihiro Sato, Pallavi Sachdev, Akihiko Koyama, Brian A. Gordon, Tammie L.S. Benzinger, David M. Holtzman, John C. Morris, Niklas Mattsson, Erik Stomrud, Rik Ossenkoppele, Suzanne E. Schindler, Oskar Hansson, Randall J. Bateman - Nature Medicine 2023 被引用: 250

  17. Blood‐based biomarkers for Alzheimer's disease

    著者: Antoine Leuzy, Niklas Mattsson, Sebastian Palmqvist, Shorena Janelidze, Jeffrey L. Dage, Oskar Hansson - EMBO Molecular Medicine 2021 被引用: 345

  18. Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care

    著者: Sebastian Palmqvist, Pontus Tideman, Niklas Mattsson, Suzanne E. Schindler, Ruben Smith, Rik Ossenkoppele, Susanna Calling, Tim West, Mark Monane, Philip B. Verghese, Joel B. Braunstein, Kaj Blennow, Shorena Janelidze, Erik Stomrud, Gemma Salvadó, Oskar Hansson - JAMA 2024 被引用: 327

  19. Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease

    著者: Shorena Janelidze, David Berron, Ruben Smith, Olof Strandberg, Nicholas K. Proctor, Jeffrey L. Dage, Erik Stomrud, Sebastian Palmqvist, Niklas Mattsson, Oskar Hansson - JAMA Neurology 2020 被引用: 374

  20. Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads

    著者: Gemma Salvadó, Rik Ossenkoppele, Nicholas J. Ashton, Thomas G. Beach, Geidy E. Serrano, Eric M. Reiman, Henrik Zetterberg, Niklas Mattsson, Shorena Janelidze, Kaj Blennow, Oskar Hansson - EMBO Molecular Medicine 2023 被引用: 202

  21. Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance

    著者: Alexa Pichet Binette, Shorena Janelidze, Nicholas Cullen, Jeffrey L. Dage, Randall J. Bateman, Henrik Zetterberg, Kaj Blennow, Erik Stomrud, Niklas Mattsson, Oskar Hansson - Alzheimer s & Dementia 2022 被引用: 219

  22. Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease

    著者: Shorena Janelidze, Erik Stomrud, Ruben Smith, Sebastian Palmqvist, Niklas Mattsson, David Airey, Nicholas K. Proctor, Xiyun Chai, Sergey Shcherbinin, John R. Sims, Gallen Triana‐Baltzer, Clara Theunis, Randy Slemmon, Marc Mercken, Hartmuth C. Kolb, Jeffrey L. Dage, Oskar Hansson - Nature Communications 2020 被引用: 453

  23. Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment

    著者: Claudia Cicognola, Shorena Janelidze, Joakim Hertze, Henrik Zetterberg, Kaj Blennow, Niklas Mattsson, Oskar Hansson - Alzheimer s Research & Therapy 2021 被引用: 303

  24. The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease

    著者: Joel Simrén, Antoine Leuzy, Thomas K. Karikari, Abdul Hye, Andréa Lessa Benedet, Juan Lantero‐Rodriguez, Niklas Mattsson, Michael Schöll, Patrizia Mecocci, Bruno Vellas, Magda Tsolaki, Iwona Kłoszewska, Hilkka Soininen, Simon Lovestone, Dag Aarsland, Oskar Hansson, Pedro Rosa‐Neto, Eric Westman, Kaj Blennow, Henrik Zetterberg, Nicholas J. Ashton - Alzheimer s & Dementia 2021 被引用: 351